Though guidelines suggest screening starts at 50, researcher says it's premature to change them
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Fresh data on pancreatic cancer are presented in the report 'Overexpression of glucocorticoid receptor in human pancreatic cancer and in xenografts. An immunohistochemical study.' Glucocorticoid receptor overexpression has been reported in a variety of human solid tumors, but much less in known about its presence in pancreatic cancer.
We care about your feedback. Let us know how we can improve your CancerCompass experience.